Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a valuable class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, stimulating https://susanwnxi808688.newbigblog.com/42277379/new-glucagon-like-peptide-1-receptor-agonists-a-comprehensive-review